Granuloma Formation around Filarial Larvae Triggered by Host Responses to an Excretory/Secretory Antigen
暂无分享,去创建一个
L. Shultz | G. Munirathinam | T. Rajan | M. Ramesh | R. Kalyanasundaram | Y. Dash | Thiruchandurai V. Rajan | Gnanasekar Munirathinam
[1] C. McGuiness,et al. THE L3 TO L4 MOLT OF BRUGIA MALAYI: REAL TIME VISUALIZATION BY VIDEO MICROSCOPY , 2005, The Journal of parasitology.
[2] I. Kalajzic,et al. Ascorbic Acid Is a Requirement for the Morphogenesis of the Human Filarial Parasite Brugia malayi , 2003, The Journal of parasitology.
[3] L. Shultz,et al. Brugian infections in the peritoneal cavities of laboratory mice: kinetics of infection and cellular responses. , 2002, Experimental parasitology.
[4] Jianzhu Chen,et al. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. , 1998, Journal of immunology.
[5] P. Pandiaraja,et al. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. , 2007, Experimental parasitology.
[6] W. F. Gregory,et al. The Abundant Larval Transcript-1 and -2 Genes ofBrugia malayi Encode Stage-Specific Candidate Vaccine Antigens for Filariasis , 2000, Infection and Immunity.
[7] J. Franssen,et al. Monoclonal antibodies against urokinase , 1981, Bioscience reports.
[8] L. Shultz,et al. B1 B Lymphocytes Play a Critical Role in Host Protection against Lymphatic Filarial Parasites , 2000, The Journal of experimental medicine.
[9] L. Shultz,et al. T Cells Are Required for Host Protection against Brugia malayi but Need Not Produce or Respond to Interleukin-4 , 2003, Infection and Immunity.
[10] M. Boes,et al. Role of natural and immune IgM antibodies in immune responses. , 2000, Molecular immunology.
[11] F. K. Nelson,et al. The immunodeficient scid mouse as a model for human lymphatic filariasis , 1991, The Journal of experimental medicine.
[12] J. McCarthy,et al. The Larval Specific Lymphatic Filarial ALT‐2: Induction of Protection Using Protein or DNA Vaccination , 2004, Microbiology and immunology.
[13] F. K. Nelson,et al. Infectivity and normal development of third stage Brugia malayi maintained in vitro. , 1994, The Journal of parasitology.
[14] Linda A. Murray,et al. Abundant larval transcript-1 and -2 genes from Brugia malayi: diversity of genomic environments but conservation of 5' promoter sequences functional in Caenorhabditis elegans. , 2002, Molecular and biochemical parasitology.
[15] V. Pandey,et al. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis. , 2009, The American journal of tropical medicine and hygiene.
[16] P. Kaliraj,et al. Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice. , 2008, Acta tropica.
[17] T. Nutman,et al. Novel Phage Display-Based Subtractive Screening To Identify Vaccine Candidates of Brugia malayi , 2004, Infection and Immunity.
[18] T. Ramalingam,et al. Critical Role for IgM in Host Protection in Experimental Filarial Infection , 2005, The Journal of Immunology.